Volume 20, Issue 1

Search all Pituitary articles

Volume 20, Issue 1

February 2017

Special Issue on Acromegaly

Issue Editors:

Maria Fleseriu,
Monica Gadelha

23 articles in this issue

David L. Kleinberg: in memoriam

In Memoriam 24 February 2017 Pages: 1 - 1
Acromegaly, a pituitary special issue
Maria Fleseriu
Monica Gadelha
EditorialNotes 02 March 2017 Pages: 2 - 3
Epidemiology of acromegaly: review of population studies
Aikaterini Lavrentaki
Alessandro Paluzzi
Niki Karavitaki
ReviewPaper Open access 14 October 2016 Pages: 4 - 9
The genetic background of acromegaly
Mônica R. Gadelha
Leandro Kasuki
Márta Korbonits
ReviewPaper Open access 04 February 2017 Pages: 10 - 21
Acromegaly: clinical features at diagnosis
Lucio Vilar
Clarice Freitas Vilar
Luciana A. Naves
ReviewPaper 03 November 2016 Pages: 22 - 32
Biochemical investigations in diagnosis and follow up of acromegaly
Katharina Schilbach
Christian J. Strasburger
Martin Bidlingmaier
ReviewPaper 06 February 2017 Pages: 33 - 45
Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
Rosario Pivonello
Renata S. Auriemma
Annamaria Colao
ReviewPaper 21 February 2017 Pages: 46 - 62
Acromegalic osteopathy
G. Mazziotti
F. Maffezzoni
A. Giustina
ReviewPaper 05 October 2016 Pages: 63 - 69
Complications of acromegaly: thyroid and colon
Amit Tirosh
Ilan Shimon
ReviewPaper 08 September 2016 Pages: 70 - 75
The surgical treatment of acromegaly
Michael Buchfelder
Sven-Martin Schlaffer
ReviewPaper 21 October 2016 Pages: 76 - 83
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary
Luis V. Syro
Fabio Rotondo
Kalman Kovacs
ReviewPaper 01 September 2016 Pages: 84 - 92
Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
Anat Ben-Shlomo
Ning-Ai Liu
Shlomo Melmed
ReviewPaper 29 November 2016 Pages: 93 - 99
Somatostatin receptor ligands in the treatment of acromegaly
Monica R. Gadelha
Luiz Eduardo Wildemberg
Diego Ferone
ReviewPaper 07 February 2017 Pages: 100 - 108
Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance
Rosa Maria Paragliola
Salvatore Maria Corsello
Roberto Salvatori
ReviewPaper 24 October 2016 Pages: 109 - 115
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
Iulia Potorac
Albert Beckers
Jean-François Bonneville
ReviewPaper 14 February 2017 Pages: 116 - 120
Cabergoline in acromegaly
Emmanuelle Kuhn
Philippe Chanson
ReviewPaper 26 December 2016 Pages: 121 - 128
Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly
Nicholas A. Tritos
Beverly M. K. Biller
OriginalPaper 08 September 2016 Pages: 129 - 135
The role of combination medical therapy in the treatment of acromegaly
Dawn Shao Ting Lim
Maria Fleseriu
ReviewPaper 13 August 2016 Pages: 136 - 148
New medical therapies on the horizon: oral octreotide
Nienke R. Biermasz
ReviewPaper Open access 16 January 2017 Pages: 149 - 153
Updates in outcomes of stereotactic radiation therapy in acromegaly
Monica Livia Gheorghiu
Review 16 February 2017 Pages: 154 - 168
Management of aggressive growth hormone secreting pituitary adenomas
Daniel A. Donoho
Namrata Bose
John D. Carmichael
ReviewPaper 16 December 2016 Pages: 169 - 178
Pregnancy and acromegaly
Ammar Muhammad
Sebastian J. Neggers
Aart J. van der Lely
ReviewPaper Open access 27 August 2016 Pages: 179 - 184
Update on quality of life in patients with acromegaly
Iris Crespo
Elena Valassi
Susan M. Webb
ReviewPaper 11 October 2016 Pages: 185 - 188

Volume 20, Issue 1

David L. Kleinberg: in memoriam

Acromegaly, a pituitary special issue

Epidemiology of acromegaly: review of population studies

The genetic background of acromegaly

Acromegaly: clinical features at diagnosis

Biochemical investigations in diagnosis and follow up of acromegaly

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities

Acromegalic osteopathy

Complications of acromegaly: thyroid and colon

The surgical treatment of acromegaly

Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary

Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas

Somatostatin receptor ligands in the treatment of acromegaly

Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance

T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective

Cabergoline in acromegaly

Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly

The role of combination medical therapy in the treatment of acromegaly

New medical therapies on the horizon: oral octreotide

Updates in outcomes of stereotactic radiation therapy in acromegaly

Management of aggressive growth hormone secreting pituitary adenomas

Pregnancy and acromegaly

Update on quality of life in patients with acromegaly

Navigation